Evaluation of structural changes in orbitofrontal cortex in relation to medication overuse in migraine patients: a diffusion tensor imaging study

Autor: Aygul Tantik Pak, Sebahat Nacar Dogan, Yildizhan Sengul

Publikováno v: Arquivos de Neuro-Psiquiatria, Vol 79, Iss 6, Pp 483-488 (2021)

Abstract Background: Migraine is a prevalent neurological disease that leads to severe headaches. Moreover, it is the commonest among the primary headaches that cause medication overuse headache (MOH). The orbitofrontal cortex (OFC) is one of the str

Externí odkaz: https://doaj.org/article/58eee6c54b7649cf95480d746750e4cd

The Effect of STAF Score and Clinical Data on Paroxysmal Atrial Fibrillation Determination in Patients with Cryptogenic Stroke

Autor: Aygül Tantik Pak, Zahide Mail Gürkan, Yıldızhan Şengül

Publikováno v: Türk Nöroloji Dergisi, Vol 26, Iss 3, Pp 207-211 (2020)

Objective: To determine factors that affect paroxysmal atrial fibrillation (PAF) detection. In this regard, we evaluated the relationship between clinical and demographic data, score for the targeting of atrial fibrillation (STAF) score, CHA2DS2-VASc

Externí odkaz: https://doaj.org/article/5ea106a647784e14bde70df49a49b8f1

Essential Tremor and Alexithymia

Autor: Yıldızhan Şengül, Hakan Serdar Şengül, Elif Gökçal, İsmet Üstün, Ahmet Öztürk, Onur Yılmaz, Gülsen Babacan Yıldız

Publikováno v: Türk Nöroloji Dergisi, Vol 24, Iss 3, Pp 248-251 (2018)

Objective: Essential tremor (ET) is the most common cause of tremor. We know that this disease, which was presumed to be monosymptomatic until recently, may be accompanied by motor findings and a series of non-motor findings other than action tremor.

Externí odkaz: https://doaj.org/article/e4887f7e49ac4011a4f97b93ff9c33ed

Cognitive Impairment in Young Multiple Sclerosis and Essential Tremor Patients: A Comparative Study

Autor: Hakan Serdar Şengül, Yıldızhan Şengül, Selma Yücel, Hulki Forta

Publikováno v: Türk Nöroloji Dergisi, Vol 22, Iss 3, Pp 109-113 (2016)

Objective: In multiple sclerosis (MS); memory, attention, information processing speed, and executive function deficits associated with cortical demyelination and atrophy can be seen in the early phases. In essential tremor (ET) cognitive impairment

Externí odkaz: https://doaj.org/article/aa1f03b496d148b981fcf99e2964a25a

Phenotype screens of murine pancreatic cancer identify a Tgf-α-Ccl2-paxillin axis driving human-like neural invasion.

Autor: Wang X; Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.; CRC 1321 Modelling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China., Istvanffy R; Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.; CRC 1321 Modelling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; Neural Influences in Cancer (NIC) International Research Consortium., Ye L; Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.; CRC 1321 Modelling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; Pain Clinic, Department of Anesthesiology, First Affiliated Hospital of USTC (Anhui Provincial Hospital), Division of Life Sciences and Medicine, University of Science and Technology of China (USTC), Hefei, China., Teller S; Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.; CRC 1321 Modelling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany., Laschinger M; Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany., Diakopoulos KN; CRC 1321 Modelling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; Comprehensive Cancer Center München, Chair for Tumor Metabolism, Klinikum rechts der Isar, Technical University of Munich, Munich, Bavaria, Germany., Görgülü K; CRC 1321 Modelling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; Comprehensive Cancer Center München, Chair for Tumor Metabolism, Klinikum rechts der Isar, Technical University of Munich, Munich, Bavaria, Germany., Li Q; Charité - Universitätsmedizin Berlin, Berlin, Germany., Ren L; Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.; CRC 1321 Modelling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany., Jäger C; Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.; CRC 1321 Modelling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany., Steiger K; CRC 1321 Modelling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; Comparative Experimental Pathology and Institute of Pathology, Technical University of Munich, School of Medicine, Munich, Germany., Muckenhuber A; CRC 1321 Modelling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; Comparative Experimental Pathology and Institute of Pathology, Technical University of Munich, School of Medicine, Munich, Germany., Vilne B; Bioinformatics laboratory, Riga Stradins University, Riga, Latvia., Çifcibaşı K; Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.; CRC 1321 Modelling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany., Reyes CM; Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.; CRC 1321 Modelling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; Neural Influences in Cancer (NIC) International Research Consortium., Yurteri Ü; Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.; CRC 1321 Modelling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany., Kießler M; Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.; CRC 1321 Modelling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany., Gürçınar IH; Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.; CRC 1321 Modelling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany., Sugden M; Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.; CRC 1321 Modelling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany., Yıldızhan SE; Department of Bioinformatics and Medical Informatics., Sezerman OU; Department of Bioinformatics and Medical Informatics., Çilingir S; Department of Physiology, Acibadem Mehmet Ali Aydinlar University, School of Medicine, Istanbul, Turkey., Süyen G; Department of Physiology, Acibadem Mehmet Ali Aydinlar University, School of Medicine, Istanbul, Turkey., Reichert M; CRC 1321 Modelling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Department of Internal Medicine II, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany., Schmid RM; CRC 1321 Modelling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Department of Internal Medicine II, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany., Bärthel S; CRC 1321 Modelling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; Institute of Translational Cancer Research (TranslaTUM) and Experimental Cancer Therapy., Oellinger R; CRC 1321 Modelling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; Institute of Molecular Oncology and Functional Genomics., Krüger A; Institute of Experimental Oncology and Therapy Research, School of Medicine, Technical University Munich, Munich, Germany., Rad R; CRC 1321 Modelling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Institute of Molecular Oncology and Functional Genomics., Saur D; CRC 1321 Modelling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Institute of Translational Cancer Research (TranslaTUM) and Experimental Cancer Therapy., Algül H; CRC 1321 Modelling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; Comprehensive Cancer Center München, Chair for Tumor Metabolism, Klinikum rechts der Isar, Technical University of Munich, Munich, Bavaria, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany., Friess H; Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.; CRC 1321 Modelling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; Neural Influences in Cancer (NIC) International Research Consortium.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany., Lesina M; CRC 1321 Modelling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; Comprehensive Cancer Center München, Chair for Tumor Metabolism, Klinikum rechts der Isar, Technical University of Munich, Munich, Bavaria, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany., Ceyhan GO; Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.; Neural Influences in Cancer (NIC) International Research Consortium.; Department of General Surgery, HPB-Unit, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey., Demir IE; Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.; CRC 1321 Modelling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; Neural Influences in Cancer (NIC) International Research Consortium.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Department of General Surgery, HPB-Unit, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.; Else Kröner Clinician Scientist Professor for Translational Pancreatic Surgery, Technical University of Munich, Munich, Germany.

Publikováno v: The Journal of clinical investigation [J Clin Invest] 2023 Nov 01; Vol. 133 (21). Date of Electronic Publication: 2023 Nov 01.